PROTECTIVE ACTIVITY OF THE LIPID-A ANALOG GLA-60 AGAINST MURINE CYTOMEGALOVIRUS-INFECTION IN IMMUNODEFICIENT MICE

被引:6
作者
IKEDA, S
NEYTS, J
MATSUURA, M
KISO, M
HASEGAWA, A
NISHIMURA, C
DECLERCQ, E
机构
[1] KITASATO UNIV,SCH PHARMACEUT SCI,TOKYO 108,JAPAN
[2] JICHI MED SCH,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
[3] GIFU UNIV,FAC AGR,GIFU 50111,JAPAN
关键词
D O I
10.1099/0022-1317-74-7-1399
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The immunomodulating and murine cytomegalovirus (MCMV)-inhibiting effects of the synthetic lipid A subunit analogue GLA-60 were investigated in different strains of immunodeficient mice. Peritoneal natural killer (NK) cells obtained from nude (nu/nu) C57BL/6 mice or normal NMRI mice, which had been treated intraperitoneally with 10 mug of GLA-60 1 day earlier, exhibited a greater cytolytic activity than those from untreated mice. GLA-60 also stimulated NK cell activity in SCID (severe combined immune deficiency) mice (which are T and B cell-defective), but not in NK cell-defective beige (C57BL/6 bg/bg) mice. GLA-60 also enhanced the phagocytic activity of peritoneal macrophages in beige, nude and NMRI mice, but not in SCID mice. GLA-60, when administered as a single 150 mug dose 1 day before infection, completely protected beige mice against MCMV-associated mortality. It also caused a significant increase in the life-span of MCMV-infected nude and SCID mice.
引用
收藏
页码:1399 / 1403
页数:5
相关论文
共 34 条
  • [1] PROTECTIVE EFFECT OF EARLY SERUM FROM MICE AFTER CYTOMEGALOVIRUS-INFECTION
    ARAULLOCRUZ, TP
    HO, M
    ARMSTRONG, JA
    [J]. INFECTION AND IMMUNITY, 1978, 21 (03) : 840 - 842
  • [2] A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE
    BOSMA, GC
    CUSTER, RP
    BOSMA, MJ
    [J]. NATURE, 1983, 301 (5900) : 527 - 530
  • [3] BRITT WJ, 1991, TRANSPLANT P, V23, P115
  • [4] EMANUEL D, 1990, SEMIN HEMATOL, V27, P22
  • [5] PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS
    ERICE, A
    CHOU, S
    BIRON, KK
    STANAT, SC
    BALFOUR, HH
    JORDAN, MC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) : 289 - 293
  • [6] ENHANCEMENT OF NONSPECIFIC RESISTANCE TO VIRAL-INFECTION BY CHEMICALLY SYNTHESIZED LIPID A-SUBUNIT ANALOGS WITH DIFFERENT BACKBONE STRUCTURES AND ACYL-GROUPS
    IKEDA, S
    KUMAZAWA, Y
    NISHIMURA, C
    NAKATSUKA, M
    HOMMA, JY
    KISO, M
    HASEGAWA, A
    [J]. ANTIVIRAL RESEARCH, 1988, 10 (4-5) : 167 - 178
  • [7] ANTIVIRAL AND IMMUNOMODULATING ACTIVITIES OF CHEMICALLY SYNTHESIZED LIPID A-SUBUNIT ANALOGS GLA-27 AND GLA-60
    IKEDA, S
    NISHIMURA, C
    NAKATSUKA, M
    HOMMA, JY
    KISO, M
    HASEGAWA, A
    [J]. ANTIVIRAL RESEARCH, 1988, 9 (1-2) : 37 - 46
  • [8] IKEDA S, 1990, J CLIN LAB IMMUNOL, V32, P189
  • [9] ANTIHERPES ACTIVITY OF CHEMICALLY SYNTHESIZED LIPID A-SUBUNIT ANALOG GLA-60 IN IMMUNOSUPPRESSED MICE
    IKEDA, S
    TOMINAGA, T
    NISHIMURA, C
    HOMMA, JY
    KISO, M
    HASEGAWA, A
    [J]. ANTIVIRAL RESEARCH, 1989, 11 (04) : 173 - 180
  • [10] IKEDA S, 1993, IN PRESS J MED VIROL